Vicore Pharma Holding AB
Developing novel ATRAG drugs for severe respiratory diseases.
Översikt
- 5–9
- Anställda
- 100–500milj SEK
- Omsättning
- 2005
- Grundat
Beskrivning
Vicore is an innovative, clinical-stage pharmaceutical company focused on developing life-changing treatments for severe diseases where the AT2 receptor plays a central role. Their primary ambition is unlocking the potential of Angiotensin II Type 2 Receptor Agonists (ATRAGs), a new class of drugs w...